Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Protein Drugs market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Protein Drugs market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Protein Drugs market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Protein Drugs products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Protein Drugs products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Protein Drugs market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Protein Drugs development has been the leading industry trend of Protein Drugs market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Protein Drugs Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Cytokines,Antibodies,Blood products,Peptide antibiotics,Vaccines,Enzymes,Peptide hormones |
| By Application Outlook |
Hospitals,Clinics,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Baxter healthcare,Btg international,Alexion pharmaceuticals,Johnson & johnson,Biogen,Amgen,Eisai,Novo nordisk,Eli lilly,Alcon,Omrix biopharmaceuticals,Hospira,Octapharma pharmazeutika produktionsges.m.b.h,Glaxosmithkline,Novartis,Hoffman-la-roche,Kamada,Dendreon,Biotest pharmaceuticals,Pfizer,Allergan,Protein sciences corporation,Cangene,Fresenius kabi,Abbott laboratories,Merck,Lundbeck,Csl,Grifols biologicals,Bristol-myers squibb,Mylan,Boehringer ingelheim,Janssen-cilag,Bio products laboratory,Bayer healthcare pharmaceuticals,Kedrion biopharmaceuticals, spa,Ferring pharmaceuticals,Medimmune,Nabi biopharmaceuticals (now biota pharmaceuticals),Affymax |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Baxter healthcare
- Btg international
- Alexion pharmaceuticals
- Johnson & johnson
- Biogen
- Amgen
- Eisai
- Novo nordisk
- Eli lilly
- Alcon
- Omrix biopharmaceuticals
- Hospira
- Octapharma pharmazeutika produktionsges.m.b.h
- Glaxosmithkline
- Novartis
- Hoffman-la-roche
- Kamada
- Dendreon
- Biotest pharmaceuticals
- Pfizer
- Allergan
- Protein sciences corporation
- Cangene
- Fresenius kabi
- Abbott laboratories
- Merck
- Lundbeck
- Csl
- Grifols biologicals
- Bristol-myers squibb
- Mylan
- Boehringer ingelheim
- Janssen-cilag
- Bio products laboratory
- Bayer healthcare pharmaceuticals
- Kedrion biopharmaceuticals
- spa
- Ferring pharmaceuticals
- Medimmune
- Nabi biopharmaceuticals (now biota pharmaceuticals)
- Affymax
PROTEIN DRUGS Market, By Type
- Cytokines
- Antibodies
- Blood products
- Peptide antibiotics
- Vaccines
- Enzymes
- Peptide hormones
PROTEIN DRUGSMarket, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Global Protein Drugs Industry Market Research Report
1 Protein Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Protein Drugs
1.3 Protein Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Protein Drugs Value ($) and Growth Rate from 2014-2026
1.4 Market Segmentation
1.4.1 Types of Protein Drugs
1.4.2 Applications of Protein Drugs
1.4.3 Research Regions
1.4.3.1 North America Protein Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.2 Europe Protein Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.3 China Protein Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.4 Japan Protein Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.5 Middle East & Africa Protein Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.6 India Protein Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.7 South America Protein Drugs Production Value ($) and Growth Rate (2014-2019)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Protein Drugs
1.5.1.2 Growing Market of Protein Drugs
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Protein Drugs Analysis
2.2 Major Players of Protein Drugs
2.2.1 Major Players Manufacturing Base and Market Share of Protein Drugs in 2018
2.2.2 Major Players Product Types in 2018
2.3 Protein Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Protein Drugs
2.3.3 Raw Material Cost of Protein Drugs
2.3.4 Labor Cost of Protein Drugs
2.4 Market Channel Analysis of Protein Drugs
2.5 Major Downstream Buyers of Protein Drugs Analysis
3 Global Protein Drugs Market, by Type
3.1 Global Protein Drugs Value ($) and Market Share by Type (2014-2019)
3.2 Global Protein Drugs Production and Market Share by Type (2014-2019)
3.3 Global Protein Drugs Value ($) and Growth Rate by Type (2014-2019)
3.4 Global Protein Drugs Price Analysis by Type (2014-2019)
4 Protein Drugs Market, by Application
4.1 Global Protein Drugs Consumption and Market Share by Application (2014-2019)
4.2 Downstream Buyers by Application
4.3 Global Protein Drugs Consumption and Growth Rate by Application (2014-2019)
5 Global Protein Drugs Production, Value ($) by Region (2014-2019)
5.1 Global Protein Drugs Value ($) and Market Share by Region (2014-2019)
5.2 Global Protein Drugs Production and Market Share by Region (2014-2019)
5.3 Global Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.4 North America Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.5 Europe Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.6 China Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.7 Japan Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.8 Middle East & Africa Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.9 India Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.10 South America Protein Drugs Production, Value ($), Price and Gross Margin (2014-2019)
6 Global Protein Drugs Production, Consumption, Export, Import by Regions (2014-2019)
6.1 Global Protein Drugs Consumption by Regions (2014-2019)
6.2 North America Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.6 Middle East & Africa Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.7 India Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.8 South America Protein Drugs Production, Consumption, Export, Import (2014-2019)
7 Global Protein Drugs Market Status and SWOT Analysis by Regions
7.1 North America Protein Drugs Market Status and SWOT Analysis
7.2 Europe Protein Drugs Market Status and SWOT Analysis
7.3 China Protein Drugs Market Status and SWOT Analysis
7.4 Japan Protein Drugs Market Status and SWOT Analysis
7.5 Middle East & Africa Protein Drugs Market Status and SWOT Analysis
7.6 India Protein Drugs Market Status and SWOT Analysis
7.7 South America Protein Drugs Market Status and SWOT Analysis
8 Competitive Landscape
8.1 Competitive Profile
8.2 Baxter healthcare
8.2.1 Company Profiles
8.2.2 Protein Drugs Product Introduction
8.2.3 Baxter healthcare Production, Value ($), Price, Gross Margin 2014-2019
8.2.4 Baxter healthcare Market Share of Protein Drugs Segmented by Region in 2018
8.3 Btg international
8.3.1 Company Profiles
8.3.2 Protein Drugs Product Introduction
8.3.3 Btg international Production, Value ($), Price, Gross Margin 2014-2019
8.3.4 Btg international Market Share of Protein Drugs Segmented by Region in 2018
8.4 Alexion pharmaceuticals
8.4.1 Company Profiles
8.4.2 Protein Drugs Product Introduction
8.4.3 Alexion pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.4.4 Alexion pharmaceuticals Market Share of Protein Drugs Segmented by Region in 2018
8.5 Johnson & johnson
8.5.1 Company Profiles
8.5.2 Protein Drugs Product Introduction
8.5.3 Johnson & johnson Production, Value ($), Price, Gross Margin 2014-2019
8.5.4 Johnson & johnson Market Share of Protein Drugs Segmented by Region in 2018
8.6 Biogen
8.6.1 Company Profiles
8.6.2 Protein Drugs Product Introduction
8.6.3 Biogen Production, Value ($), Price, Gross Margin 2014-2019
8.6.4 Biogen Market Share of Protein Drugs Segmented by Region in 2018
8.7 Amgen
8.7.1 Company Profiles
8.7.2 Protein Drugs Product Introduction
8.7.3 Amgen Production, Value ($), Price, Gross Margin 2014-2019
8.7.4 Amgen Market Share of Protein Drugs Segmented by Region in 2018
8.8 Eisai
8.8.1 Company Profiles
8.8.2 Protein Drugs Product Introduction
8.8.3 Eisai Production, Value ($), Price, Gross Margin 2014-2019
8.8.4 Eisai Market Share of Protein Drugs Segmented by Region in 2018
8.9 Novo nordisk
8.9.1 Company Profiles
8.9.2 Protein Drugs Product Introduction
8.9.3 Novo nordisk Production, Value ($), Price, Gross Margin 2014-2019
8.9.4 Novo nordisk Market Share of Protein Drugs Segmented by Region in 2018
8.10 Eli lilly
8.10.1 Company Profiles
8.10.2 Protein Drugs Product Introduction
8.10.3 Eli lilly Production, Value ($), Price, Gross Margin 2014-2019
8.10.4 Eli lilly Market Share of Protein Drugs Segmented by Region in 2018
8.11 Alcon
8.11.1 Company Profiles
8.11.2 Protein Drugs Product Introduction
8.11.3 Alcon Production, Value ($), Price, Gross Margin 2014-2019
8.11.4 Alcon Market Share of Protein Drugs Segmented by Region in 2018
8.12 Omrix biopharmaceuticals
8.12.1 Company Profiles
8.12.2 Protein Drugs Product Introduction
8.12.3 Omrix biopharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.12.4 Omrix biopharmaceuticals Market Share of Protein Drugs Segmented by Region in 2018
8.13 Hospira
8.13.1 Company Profiles
8.13.2 Protein Drugs Product Introduction
8.13.3 Hospira Production, Value ($), Price, Gross Margin 2014-2019
8.13.4 Hospira Market Share of Protein Drugs Segmented by Region in 2018
8.14 Octapharma pharmazeutika produktionsges.m.b.h
8.14.1 Company Profiles
8.14.2 Protein Drugs Product Introduction
8.14.3 Octapharma pharmazeutika produktionsges.m.b.h Production, Value ($), Price, Gross Margin 2014-2019
8.14.4 Octapharma pharmazeutika produktionsges.m.b.h Market Share of Protein Drugs Segmented by Region in 2018
8.15 Glaxosmithkline
8.15.1 Company Profiles
8.15.2 Protein Drugs Product Introduction
8.15.3 Glaxosmithkline Production, Value ($), Price, Gross Margin 2014-2019
8.15.4 Glaxosmithkline Market Share of Protein Drugs Segmented by Region in 2018
8.16 Novartis
8.16.1 Company Profiles
8.16.2 Protein Drugs Product Introduction
8.16.3 Novartis Production, Value ($), Price, Gross Margin 2014-2019
8.16.4 Novartis Market Share of Protein Drugs Segmented by Region in 2018
8.17 Hoffman-la-roche
8.18 Kamada
8.19 Dendreon
8.20 Biotest pharmaceuticals
8.21 Pfizer
8.22 Allergan
8.23 Protein sciences corporation
8.24 Cangene
8.25 Fresenius kabi
8.26 Abbott laboratories
8.27 Merck
8.28 Lundbeck
8.29 Csl
8.30 Grifols biologicals
8.31 Bristol-myers squibb
8.32 Mylan
8.33 Boehringer ingelheim
8.34 Janssen-cilag
8.35 Bio products laboratory
8.36 Bayer healthcare pharmaceuticals
8.37 Kedrion biopharmaceuticals, spa
8.38 Ferring pharmaceuticals
8.39 Medimmune
8.40 Nabi biopharmaceuticals (now biota pharmaceuticals)
8.41 Affymax
9 Global Protein Drugs Market Analysis and Forecast by Type and Application
9.1 Global Protein Drugs Market Value ($) & Volume Forecast, by Type (2019-2026)
9.1.1 Cytokines Market Value ($) and Volume Forecast (2019-2026)
9.1.2 Antibodies Market Value ($) and Volume Forecast (2019-2026)
9.1.3 Blood products Market Value ($) and Volume Forecast (2019-2026)
9.1.4 Peptide antibiotics Market Value ($) and Volume Forecast (2019-2026)
9.1.5 Vaccines Market Value ($) and Volume Forecast (2019-2026)
9.1.6 Enzymes Market Value ($) and Volume Forecast (2019-2026)
9.1.7 Peptide hormones Market Value ($) and Volume Forecast (2019-2026)
9.2 Global Protein Drugs Market Value ($) & Volume Forecast, by Application (2019-2026)
9.2.1 Application 1 Market Value ($) and Volume Forecast (2019-2026)
9.2.2 Application 2 Market Value ($) and Volume Forecast (2019-2026)
9.2.3 Application 3 Market Value ($) and Volume Forecast (2019-2026)
9.2.4 Application 4 Market Value ($) and Volume Forecast (2019-2026)
9.2.5 Application 5 Market Value ($) and Volume Forecast (2019-2026)
10 Protein Drugs Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2019-2026)
10.2 Europe Market Value ($) and Consumption Forecast (2019-2026)
10.3 China Market Value ($) and Consumption Forecast (2019-2026)
10.4 Japan Market Value ($) and Consumption Forecast (2019-2026)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2026)
10.6 India Market Value ($) and Consumption Forecast (2019-2026)
10.7 South America Market Value ($) and Consumption Forecast (2019-2026)
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
